MX2010004482A - Anticuerpos anti-proteina g vsr. - Google Patents
Anticuerpos anti-proteina g vsr.Info
- Publication number
- MX2010004482A MX2010004482A MX2010004482A MX2010004482A MX2010004482A MX 2010004482 A MX2010004482 A MX 2010004482A MX 2010004482 A MX2010004482 A MX 2010004482A MX 2010004482 A MX2010004482 A MX 2010004482A MX 2010004482 A MX2010004482 A MX 2010004482A
- Authority
- MX
- Mexico
- Prior art keywords
- rsv
- protein antibodies
- protein
- fragments
- bind
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 108091006027 G proteins Proteins 0.000 abstract 1
- 102000030782 GTP binding Human genes 0.000 abstract 1
- 108091000058 GTP-Binding Proteins 0.000 abstract 1
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Los anticuerpos monoclonales individuales y fragmentos que se unen a un epítope conservado de la proteína G del VSR y que son mínimamente inmunogénicos cuando se administran a un sujeto humano, son útiles en el tratamiento de infecciones por VSR.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46907P | 2007-10-25 | 2007-10-25 | |
US8940108P | 2008-08-15 | 2008-08-15 | |
PCT/US2008/081175 WO2009055711A2 (en) | 2007-10-25 | 2008-10-24 | Anti-rsv g protein antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004482A true MX2010004482A (es) | 2010-07-06 |
Family
ID=40580419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004482A MX2010004482A (es) | 2007-10-25 | 2008-10-24 | Anticuerpos anti-proteina g vsr. |
Country Status (14)
Country | Link |
---|---|
US (3) | US7736648B2 (es) |
EP (1) | EP2214711B1 (es) |
JP (2) | JP5808536B2 (es) |
KR (1) | KR101671452B1 (es) |
CN (1) | CN101808663B (es) |
AU (1) | AU2008316703B2 (es) |
BR (1) | BRPI0819210A2 (es) |
CA (1) | CA2703667C (es) |
IL (1) | IL205257A (es) |
MX (1) | MX2010004482A (es) |
NZ (1) | NZ585589A (es) |
RU (1) | RU2526517C2 (es) |
WO (1) | WO2009055711A2 (es) |
ZA (1) | ZA201003131B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040170677A1 (en) * | 2002-11-26 | 2004-09-02 | Ning Hu | Method of drug loading in liposomes by gradient |
US7736648B2 (en) * | 2007-10-25 | 2010-06-15 | Trellis Bioscience, Inc. | Anti-RSV G protein antibodies |
EP2780366A2 (en) | 2011-11-17 | 2014-09-24 | AIMM Therapeutics B.V. | Rsv g protein specific antibodies |
AU2013206789B2 (en) * | 2011-12-28 | 2017-04-13 | Immunoqure Ag | Method of isolating human antibodies |
US10131709B2 (en) | 2011-12-28 | 2018-11-20 | Immunoqure Ag | Nucleic acid molecules encoding monoclonal antibodies specific for IL-22 |
WO2013119419A1 (en) | 2012-02-08 | 2013-08-15 | North Carolina State University | Treatment of allergic diseases with recombinant antibodies |
TWI659968B (zh) | 2013-03-14 | 2019-05-21 | 再生元醫藥公司 | 針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法 |
CN111303278B (zh) * | 2013-04-15 | 2022-09-06 | 扬森疫苗与预防公司 | 结合到rsv g蛋白的人类抗体 |
US10196438B2 (en) | 2013-04-15 | 2019-02-05 | Janssen Vaccines & Prevention B.V. | Human antibodies binding to RSV G protein |
AU2014255865B2 (en) | 2013-04-15 | 2019-07-18 | Janssen Vaccines & Prevention B.V. | Human antibodies binding to RSV G proteins |
CN105992772A (zh) * | 2014-02-10 | 2016-10-05 | Igm生命科学股份有限公司 | IgA多特异性结合分子 |
CN103911389A (zh) * | 2014-04-09 | 2014-07-09 | 南昌大学 | 一种检测人呼吸道合胞病毒抗体的g和f蛋白的制备方法 |
KR20230159637A (ko) | 2014-12-05 | 2023-11-21 | 메모리얼 슬로안 케터링 캔서 센터 | G-단백질 커플화 수용체를 표적화하는 항체 및 이의 사용 방법 |
HUE057777T2 (hu) | 2014-12-05 | 2022-06-28 | Memorial Sloan Kettering Cancer Center | Kiméra antigén receptorok, amelyek G-fehérje-kapcsolt receptort céloznak meg, és a receptorok alkalmazásai |
CN106496324B (zh) * | 2015-11-30 | 2020-01-14 | 天津昊免生物技术有限公司 | 一种抗呼吸道合胞病毒的全人源抗体 |
CN105542003B (zh) * | 2016-03-01 | 2019-12-06 | 苏州博泰神州生物技术有限公司 | 一种针对rsv粘附g蛋白表面抗原的全人源单克隆抗体 |
CA3041717A1 (en) | 2016-11-09 | 2018-05-17 | North Carolina State University | Treatment of allergic diseases with chimeric protein |
EP3573651A4 (en) | 2017-01-27 | 2020-10-14 | NGM Biopharmaceuticals, Inc. | GLUCAGON RECEPTOR BINDING PROTEINS AND METHODS OF USE |
CA3079604A1 (en) * | 2017-10-13 | 2019-04-18 | Trellis Bioscience, Llc | Conformational epitopes in respiratory syncytial virus g protein central conserved region |
WO2020023847A1 (en) | 2018-07-27 | 2020-01-30 | Ngm Biopharmaceuticals, Inc. | Use of glucagon receptor antagonists with immunotherapeutic agent |
EP3833677A4 (en) * | 2018-08-08 | 2022-04-27 | Trellis Bioscience, Inc. | IMPROVED PASSIVE AND ACTIVE VACCINES AGAINST RSV |
US20220362371A1 (en) * | 2019-09-20 | 2022-11-17 | Universiteit Antwerpen | Human respiratory syncytial virus strain and its use |
WO2024027708A1 (zh) * | 2022-08-02 | 2024-02-08 | 诺纳生物(苏州)有限公司 | Msln抗体药物偶联物 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3734263B2 (ja) * | 1993-05-25 | 2006-01-11 | ワイス・ホールディングズ・コーポレイション | 呼吸器シンシチウムウイルスに対するワクチンのためのアジュバント |
US6020182A (en) * | 1996-07-12 | 2000-02-01 | Connaught Laboratories Limited | Subunit respiratory syncytial virus vaccine preparation |
FR2766192B1 (fr) * | 1997-07-17 | 2001-07-13 | Pf Medicament | Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie |
US6642062B2 (en) | 1998-09-03 | 2003-11-04 | Trellis Bioinformatics, Inc. | Multihued labels |
US7083950B2 (en) | 1998-09-25 | 2006-08-01 | Regeneron Pharmaceuticals, Inc. | High affinity fusion proteins and therapeutic and diagnostic methods for use |
AU770737B2 (en) | 1999-01-22 | 2004-03-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies |
ATE412666T1 (de) * | 2000-10-18 | 2008-11-15 | Us Gov Health & Human Serv | Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität |
US7413868B2 (en) | 2003-11-05 | 2008-08-19 | Trellis Bioscience, Inc. | Use of particulate labels in bioanalyte detection methods |
JP4736037B2 (ja) * | 2005-10-26 | 2011-07-27 | 株式会社イーベック | ヒトgm−csfに結合するヒトのモノクローナル抗体並びにその抗原結合部分 |
CN1986569A (zh) * | 2005-12-23 | 2007-06-27 | 首都儿科研究所 | 人源抗呼吸道合胞病毒中和性基因工程Fab抗体 |
WO2007094423A1 (ja) | 2006-02-15 | 2007-08-23 | Evec Incorporated | ヒトサイトメガロウイルスに結合するヒトのモノクローナル抗体並びにその抗原結合部分 |
EP2004686A1 (en) * | 2006-03-06 | 2008-12-24 | Symphogen A/S | Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
JP2009544014A (ja) | 2006-07-12 | 2009-12-10 | トレリス バイオサイエンス、インク. | セルスポット・アプリケーション |
US7736648B2 (en) * | 2007-10-25 | 2010-06-15 | Trellis Bioscience, Inc. | Anti-RSV G protein antibodies |
-
2008
- 2008-10-24 US US12/258,260 patent/US7736648B2/en active Active
- 2008-10-24 BR BRPI0819210-3A patent/BRPI0819210A2/pt not_active IP Right Cessation
- 2008-10-24 EP EP08841063.4A patent/EP2214711B1/en active Active
- 2008-10-24 KR KR1020107011433A patent/KR101671452B1/ko active IP Right Grant
- 2008-10-24 RU RU2010120879/10A patent/RU2526517C2/ru not_active IP Right Cessation
- 2008-10-24 MX MX2010004482A patent/MX2010004482A/es active IP Right Grant
- 2008-10-24 AU AU2008316703A patent/AU2008316703B2/en active Active
- 2008-10-24 WO PCT/US2008/081175 patent/WO2009055711A2/en active Application Filing
- 2008-10-24 CN CN200880117420.0A patent/CN101808663B/zh not_active Expired - Fee Related
- 2008-10-24 JP JP2010531283A patent/JP5808536B2/ja active Active
- 2008-10-24 NZ NZ585589A patent/NZ585589A/en not_active IP Right Cessation
- 2008-10-24 CA CA2703667A patent/CA2703667C/en active Active
-
2010
- 2010-04-22 IL IL205257A patent/IL205257A/en not_active IP Right Cessation
- 2010-05-04 ZA ZA2010/03131A patent/ZA201003131B/en unknown
- 2010-05-12 US US12/778,933 patent/US8273354B2/en active Active
-
2012
- 2012-09-25 US US13/626,852 patent/US9321830B2/en active Active
-
2015
- 2015-01-16 JP JP2015006644A patent/JP2015078231A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN101808663A (zh) | 2010-08-18 |
US20100285022A1 (en) | 2010-11-11 |
CA2703667A1 (en) | 2009-04-30 |
RU2010120879A (ru) | 2011-11-27 |
RU2526517C2 (ru) | 2014-08-20 |
KR101671452B1 (ko) | 2016-11-17 |
EP2214711A4 (en) | 2011-12-21 |
NZ585589A (en) | 2012-07-27 |
EP2214711A2 (en) | 2010-08-11 |
IL205257A (en) | 2014-12-31 |
US9321830B2 (en) | 2016-04-26 |
WO2009055711A2 (en) | 2009-04-30 |
AU2008316703A1 (en) | 2009-04-30 |
IL205257A0 (en) | 2010-12-30 |
US8273354B2 (en) | 2012-09-25 |
US20090130120A1 (en) | 2009-05-21 |
CN101808663B (zh) | 2015-09-30 |
AU2008316703B2 (en) | 2012-09-27 |
JP2015078231A (ja) | 2015-04-23 |
US20130034564A1 (en) | 2013-02-07 |
CA2703667C (en) | 2015-12-29 |
JP5808536B2 (ja) | 2015-11-10 |
US7736648B2 (en) | 2010-06-15 |
KR20100091195A (ko) | 2010-08-18 |
JP2011500091A (ja) | 2011-01-06 |
BRPI0819210A2 (pt) | 2015-06-23 |
WO2009055711A3 (en) | 2009-09-24 |
ZA201003131B (en) | 2011-03-30 |
AU2008316703A2 (en) | 2010-07-22 |
EP2214711B1 (en) | 2018-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010004482A (es) | Anticuerpos anti-proteina g vsr. | |
PH12019500644A1 (en) | Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections | |
PH12016500859B1 (en) | Anti-human respiratory syncytial virus (rsv) antibodies and methods of use | |
WO2011143624A3 (en) | Humanized and chimeric monoclonal antibodies to cd47 | |
MX2012001882A (es) | Anticuerpos contra el virus sincitial respiratorio (rsv) humano y metodos de uso. | |
MX2011012060A (es) | Anticuerpos humanizados específicos de la forma protofibrilar del péptido beta-miloide. | |
MX2010003574A (es) | Anticuerpos il-23. | |
UA109658C2 (xx) | Антитіло проти cgrp | |
MX2009011500A (es) | Anticuerpos anti-mdl-1. | |
UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
ECSP13012436A (es) | ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
WO2010054265A3 (en) | Monoclonal antibodies to fibroblast growth factor receptor 2 | |
WO2010136311A3 (en) | Compositions and methods for antibodies targeting complement protein c3b | |
WO2011147982A3 (en) | Monoclonal antibodies against her2 epitope | |
MX2013002046A (es) | Anticuerpos para el receptor del factor de crecimiento epidermico 3 (her3). | |
MY156286A (en) | Human il-23 antigen binding proteins | |
PT2126049E (pt) | Anticorpos contra citomegalovírus humano (hcmv) | |
UA113623C2 (uk) | Моноклональне антитіло проти інгібітору шляху тканинного фактора (tfpi) | |
WO2010056898A3 (en) | Rapid expression cloning of human monoclonal antibodies from memory b cells | |
WO2008043052A3 (en) | Human antibodies neutralizing human metapneumovirus | |
TN2009000380A1 (en) | Novel human anti-r7v antibodies and uses thereof | |
WO2009114560A3 (en) | Compositions and methods for the therapy and diagnosis of cytomegalovirus infections | |
NZ594347A (en) | Antibodies against human tweak and uses thereof | |
MX2011010634A (es) | Anticuerpos monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 01 de pseudomonas aeruginosa. | |
WO2010117455A3 (en) | Human monoclonal antibodies protective against bubonic plaque |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |